Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting

dc.contributor.authorTooke, L J
dc.contributor.authorBrowde, K
dc.contributor.authorHarrison, M C
dc.date.accessioned2016-04-29T13:30:20Z
dc.date.available2016-04-29T13:30:20Z
dc.date.issued2013
dc.date.updated2016-04-29T13:26:39Z
dc.description.abstractBackground: Methylxanthines such as caffeine have been proven to reduce apnoea of prematurity and are often discontinued at 35 weeks’ corrected gestational age (GA). Objective. To ascertain whether a caffeine protocol based on international guidelines is applicable in our setting, where GA is often uncertain. Methods: A prospective folder review was undertaken of all premature infants discharged home over a 2-month period. Results: Fifty-five babies were included. All babies born at less than 35 weeks’ GA were correctly started on caffeine as per protocol. GA was assigned in 85.5% of cases by Ballard scoring and in 14.5% from antenatal ultrasound findings. Caffeine was discontinued before 35 weeks in 54.5%. Discussion: The main reason for discontinuing caffeine early was the baby’s ability to feed satisfactorily, a demonstration of physiological maturity. As feeding behaviours mature significantly between 33 and 36 weeks, the ability to feed may be a good indication that caffeine therapy can be stopped.en_ZA
dc.identifierhttp://dx.doi.org/10.7196/SAJCH.630
dc.identifier.apacitationTooke, L. J., Browde, K., & Harrison, M. C. (2013). Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting. <i>South African Journal of Child Health</i>, http://hdl.handle.net/11427/19340en_ZA
dc.identifier.chicagocitationTooke, L J, K Browde, and M C Harrison "Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting." <i>South African Journal of Child Health</i> (2013) http://hdl.handle.net/11427/19340en_ZA
dc.identifier.citationTooke, L. J., Browde, K., & Harrison, M. C. (2013). Apnoea of prematurity–discontinuation of methylxanthines in a resource-limited setting. South African Journal of Child Health, 7(4), 146-147.en_ZA
dc.identifier.issn1994-3032en_ZA
dc.identifier.ris TY - Journal Article AU - Tooke, L J AU - Browde, K AU - Harrison, M C AB - Background: Methylxanthines such as caffeine have been proven to reduce apnoea of prematurity and are often discontinued at 35 weeks’ corrected gestational age (GA). Objective. To ascertain whether a caffeine protocol based on international guidelines is applicable in our setting, where GA is often uncertain. Methods: A prospective folder review was undertaken of all premature infants discharged home over a 2-month period. Results: Fifty-five babies were included. All babies born at less than 35 weeks’ GA were correctly started on caffeine as per protocol. GA was assigned in 85.5% of cases by Ballard scoring and in 14.5% from antenatal ultrasound findings. Caffeine was discontinued before 35 weeks in 54.5%. Discussion: The main reason for discontinuing caffeine early was the baby’s ability to feed satisfactorily, a demonstration of physiological maturity. As feeding behaviours mature significantly between 33 and 36 weeks, the ability to feed may be a good indication that caffeine therapy can be stopped. DA - 2013 DB - OpenUCT DP - University of Cape Town J1 - South African Journal of Child Health LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 SM - 1994-3032 T1 - Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting TI - Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting UR - http://hdl.handle.net/11427/19340 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/19340
dc.identifier.urihttp://sajch.org.za/index.php/SAJCH/article/view/630
dc.identifier.vancouvercitationTooke LJ, Browde K, Harrison MC. Apnoea of prematurity - discontinuation of methylxanthines in a resource-limited setting. South African Journal of Child Health. 2013; http://hdl.handle.net/11427/19340.en_ZA
dc.languageengen_ZA
dc.publisherHealth and Medical Publishing Groupen_ZA
dc.publisher.departmentDivision of Neonatologyen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rightsCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_ZA
dc.sourceSouth African Journal of Child Healthen_ZA
dc.source.urihttp://www.sajch.org.za/index.php/SAJCH
dc.subject.otherprematurity
dc.subject.otherapnoea
dc.subject.othercaffeine
dc.subject.othermethylxanthines
dc.titleApnoea of prematurity - discontinuation of methylxanthines in a resource-limited settingen_ZA
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Tooke_Apnoea_prematurity_2013.pdf
Size:
587.44 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections